TIDMODX

RNS Number : 2762L

Omega Diagnostics Group PLC

17 July 2017

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014

17 July 2017

Omega Diagnostics Group plc

Result of Open Offer

On 30 June 2017, Omega announced details of a Placing, Subscription and Open Offer to raise gross proceeds of approximately GBP3.6 million through the issue of up to 20,007,003 New Ordinary Shares at a price of 18 pence per share, with 13,116,881 shares subject to the Placing, 1,166,666 shares subject to the Subscription and up to a further 5,723,456 shares to be issued through the Open Offer.

The Open Offer closed for acceptances at 11.00 a.m. on 17 July 2017. Omega is pleased to announce that it has received valid applications under the Open Offer, including those received under the Excess Application Facility, in respect of 3,854,844 Open Offer Shares from Qualifying Shareholders. This represents approximately 67.4 per cent. of the Open Offer Shares. Qualifying Shareholders who have validly applied for Open Offer Shares and Excess Shares will receive their application in full.

The Placing, Subscription and Open Offer remain conditional, inter alia, upon the Resolutions being passed at the General Meeting to be held at 10.00 a.m. on 18 July 2017 and Admission. Omega expects to announce the results of the General Meeting as soon as practicable on 18 July 2017 after the meeting concludes. It is expected that Admission will become effective on 19 July 2017.

Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 30 June 2017.

Contacts:

 
 Omega Diagnostics Group PLC           Tel: 01259 763 030 
Andrew Shepherd, Chief Executive       www.omegadiagnostics.com 
Kieron Harbinson, Group Finance 
 Director 
Jag Grewal, Group Sales and Marketing 
 Director 
 
finnCap Ltd                            Tel: 020 7220 0500 
Geoff Nash/James Thompson (Corporate 
 Finance) 
Mia Gardner (Corporate Broking) 
 
Walbrook PR Limited                    Tel: 020 7933 8780 or omega@walbrookpr.com 
Paul McManus                           Mob: 07980 541 893 
Lianne Cawthorne                       Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

ROIRRMJTMBBBBAR

(END) Dow Jones Newswires

July 17, 2017 09:17 ET (13:17 GMT)

Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Omega Diagnostics Charts.
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Omega Diagnostics Charts.